Search Results - "Chester JD"

Author Index for Volume 104.

Source: British Journal of Cancer. 6/7/2011, Vol. 104 Issue 12, p1932-1940. 9p.

Author index.

Source: British Journal of Cancer. 7/2/2001 Supplement 1, Vol. 85, p110. 7p.

Photoacoustic imaging for monitoring radiotherapy treatment response in head and neck tumors.

Authors: Holzwarth, Niklas Rachel, Zoe Nölke, Jan-Hinrich et al.

Source: Scientific Reports. 5/10/2025, Vol. 15 Issue 1, p1-11. 11p.

Author Index for Volume 109.

Source: British Journal of Cancer. 12/10/2013, Vol. 109 Issue 12, p3133-3144. 12p.

A mixed methods case study investigating how randomised controlled trials (RCTs) are reported, understood and interpreted in practice.

Authors: Byrne, Ben E. Rooshenas, Leila Lambert, Helen S. et al.

Source: BMC Medical Research Methodology. 5/12/2020, Vol. 20 Issue 1, p1-12. 12p. 6 Charts.

Management of Advanced Penile Cancer.

Authors: Stelmach, Ramona Giannatempo, Patrizia Nicolai, Nicola et al.

Source: Oncology Research & Treatment. 2026, Vol. 49 Issue 1/2, p48-61. 13p.

A novel DNA damage-related gene index for predicting prognosis in gastric cancer.

Authors: Xiao, Haipeng He, Qianjin Hu, Yang et al.

Source: 3 Biotech. 1/4/2025, Vol. 15 Issue 1, p1-17. 17p.

Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer.

Authors: Denis, Chloé Sakalihasan, Sarah Frères, Pierre et al.

Source: Case Reports in Oncology. 2021, Vol. 14 Issue 2, p972-976. 5p.

Cervical lymph node metastasis of bladder cancer: a case report and review of literature.

Authors: Guolin Tian Yajie Li Lihong Nie et al.

Source: Aging Male. Dec2023, Vol. 26 Issue 1, p1-7.

Precision cancer medicine and the doctor-patient relationship: a systematic review and narrative synthesis.

Authors: Grauman, Å. Ancillotti, M. Veldwijk, J. et al.

Source: BMC Medical Informatics & Decision Making. 12/14/223, Vol. 23 Issue 1, p1-13. 13p.

Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine.

Authors: Morii, Eiichi Hatanaka, Yutaka Motoi, Noriko et al.

Source: Pathobiology. 2023, Vol. 90 Issue 5, p289-311. 23p.

INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models.

Authors: Liu, Phillip C. C. Koblish, Holly Wu, Liangxing et al.

Source: PLoS ONE. 4/21/2020, Vol. 15 Issue 4, p1-16. 16p.

Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases.

Authors: Rzepka, Dinah Schenker, Hannah Geinitz, Hans et al.

Source: Radiation Oncology. 6/7/2023, Vol. 18 Issue 1, p1-13. 13p.

Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study.

Authors: Sung Jun Sou Ja Yoon Ku Kyung Hwan Kim et al.

Source: Investigative & Clinical Urology. Mar2025, Vol. 66 Issue 2, p114-123. 11p.

Adaptive Immunity Determines the Cancer Treatment Outcome of Oncolytic Virus and Anti-PD-1: Adaptive Immunity Determines...: K.-L. Liao, K. D. Watt.

Authors: Liao, Kang-Ling Watt, Kenton D.

Source: Bulletin of Mathematical Biology. Mar2025, Vol. 87 Issue 3, p1-37. 37p.

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10.

Authors: Bates EA Davies JA Váňová J et al.

Source: Molecular therapy oncolytics [Mol Ther Oncolytics] 2022 Mar 16; Vol. 25, pp. 43-56. Date of Electronic Publication: 2022 Mar 16 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE

Mev-stealth: A cd46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.

Authors: Muñoz-Alía, Miguel Ángel Nace, Rebecca A. Tischer, Alexander et al.

Source: PLoS Pathogens. 2/3/2021, Vol. 17 Issue 2, p1-27. 27p.

Efficacy and safety of tislelizumab combined with chemotherapy for locally advanced penile cancer: a prospective, single-arm clinical study.

Authors: Shan X Bai H Ning H et al.

Source: British journal of cancer [Br J Cancer] 2026 Mar; Vol. 134 (5), pp. 764-771. Date of Electronic Publication: 2025 Dec 26.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Advanced cancer patient preferences for receiving molecular profiling results.

Authors: Best, Megan Butow, Phyllis Jacobs, Chris et al.

Source: Psycho-Oncology. Oct2020, Vol. 29 Issue 10, p1533-1539. 7p. 2 Charts.

Subjects: Medical personnel, Cancer patients, Freedom of information, Cancer treatment, Attitude (Psychology)

Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.

Authors: Su, Zijian Zhang, Yibo Cao, Jieqiong et al.

Source: Journal of Nanobiotechnology. 2/17/2023, Vol. 21 Issue 1, p1-19. 19p.